Welcome to IsraPharm - Contact us at +972 7337 468 45 (Office)

Contact Us

Office Address

Weizman 14 st., Tel Aviv, Israel

Phone Number

+972 7337 46845 (Office)

Email Address

[email protected]



Add to Wishlist
Add to Wishlist



  • Newly diagnosed Philadelphia chromosome positive (Ph+) chronic myeloid leukemia (CML) in children and adults;
  • Ph+ CML in the chronic phase with failure of previous therapy with interferon alfa or in the phase of acceleration or blast crisis in children and adults;
  • Newly diagnosed Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) in adult patients in combination with chemotherapy;
  • Relapsed or refractory Ph+ ALL in adult patients as monotherapy;
  • Myelodysplastic / myeloproliferative diseases associated with gene rearrangements of the platelet growth factor receptor in adult patients;
  • Systemic mastocytosis in adult patients with no D816V c-Kit mutation or with unknown c-Kit mutational status;
  • Hypereosinophilic syndrome and/or chronic eosinophilic leukemia in adults with positive or negative abnormal FIP1L1-PDGRF alpha tyrosine kinase;
  • Unresectable and/or metastatic malignant gastrointestinal stromal tumors positive for c-Kit (CD 117) in adult patients;
  • Adjuvant therapy of gastrointestinal stromal tumors positive for c-Kit (CD 117) in adult patients;inoperable, recurrent and/or metastatic dermatofibrosarcoma bulging in adult patients.

Active ingredient: imatinib

Prescription medicine.

Additional information


100 Mg, 400 Mg